Surgery for Obesity and Related Diseases
Volume 4, Issue 6 , Pages 715-719, November 2008

Need for parenteral iron therapy after bariatric surgery

  • Seema Varma, M.D.

      Affiliations

    • Division of Hematology and Oncology, Sanford R. Nalitt Institute for Cancer and Blood Related Diseases, Department of Medicine, Staten Island University Hospital, Staten Island, New York
  • ,
  • Walid Baz, M.D.

      Affiliations

    • Division of Hematology and Oncology, Sanford R. Nalitt Institute for Cancer and Blood Related Diseases, Department of Medicine, Staten Island University Hospital, Staten Island, New York
  • ,
  • Edgard Badine, M.D.

      Affiliations

    • Division of Hematology and Oncology, Sanford R. Nalitt Institute for Cancer and Blood Related Diseases, Department of Medicine, Staten Island University Hospital, Staten Island, New York
  • ,
  • Fadi Nakhl, M.D.

      Affiliations

    • Division of Hematology and Oncology, Sanford R. Nalitt Institute for Cancer and Blood Related Diseases, Department of Medicine, Staten Island University Hospital, Staten Island, New York
  • ,
  • Heather McMullen, M.D., F.A.C.S.

      Affiliations

    • Bariatric Surgery Program, Department of Surgery, Center for the Surgical Treatment of Obesity, Staten Island University Hospital, Staten Island, New York
  • ,
  • Jeffrey Nicastro, M.D., F.A.C.S.

      Affiliations

    • Bariatric Surgery Program, Department of Surgery, Center for the Surgical Treatment of Obesity, Staten Island University Hospital, Staten Island, New York
  • ,
  • Frank Forte, M.D.

      Affiliations

    • Division of Hematology and Oncology, Sanford R. Nalitt Institute for Cancer and Blood Related Diseases, Department of Medicine, Staten Island University Hospital, Staten Island, New York
  • ,
  • Terenig Terjanian, M.D.

      Affiliations

    • Division of Hematology and Oncology, Sanford R. Nalitt Institute for Cancer and Blood Related Diseases, Department of Medicine, Staten Island University Hospital, Staten Island, New York
  • ,
  • Qun Dai, M.D.

      Affiliations

    • Division of Hematology and Oncology, Sanford R. Nalitt Institute for Cancer and Blood Related Diseases, Department of Medicine, Staten Island University Hospital, Staten Island, New York

Received 19 December 2007; received in revised form 13 April 2008; accepted 25 April 2008. published online 01 July 2008.

Abstract 

Background

Malabsorptive bariatric procedures such as Roux-en-Y gastric bypass and biliopancreatic diversion/duodenal switch expose the patient to malnutrition and commonly cause iron deficiency. The optimal replacement and monitoring method remain undetermined. To identify high-risk patients who might need intravenous iron supplementation after bariatric surgery, we evaluated bariatric surgery patients who received parenteral iron at a university hospital-affiliated hematology center.

Methods

We performed a retrospective analysis and reviewed the records of 165 patients who had received parenteral iron from May 2004 to June 2007. Of the 165 patients, 42 bariatric surgery patients were identified. The type of bariatric procedure and menstrual status of the patients were compared.

Results

The average patient age was 40 years. Of the 42 patients, 2 were men and 40 were women. Of the 40 women, 32 were premenopausal and 8 were postmenopausal. The patients in the biliopancreatic diversion/duodenal switch group had a significantly lower hemoglobin at presentation (P = .02), relatively lower ferritin levels, and required more additional parenteral iron treatment after the initial resolution of anemia (P = .001). The premenopausal women required earlier parenteral replacement (P = .008) and were at a greater risk of anemia-related hospitalization (P = .00033).

Conclusion

The available published studies lack any data regarding parenteral iron replacement needs after bariatric surgery. Our results have identified the need for long-term parenteral iron replacement therapy after malabsorptive bariatric procedures, especially in premenopausal women. Patients who do not respond to oral iron therapy should be referred early for parenteral iron replacement therapy to prevent anemia-related complications and to maintain patients' quality of life. Iron monitoring should continue indefinitely even after the initial repletion of iron stores and the resolution of anemia.

Keywords: Obesity, Iron deficiency anemia, Bariatric surgery, Parenteral iron therapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Reprints not available from the authors.

PII: S1550-7289(08)00455-3

doi:10.1016/j.soard.2008.04.015

Surgery for Obesity and Related Diseases
Volume 4, Issue 6 , Pages 715-719, November 2008